Three years into the pandemic, the World Health Organization's Joachim Hombach talks about the future of vaccines with MarketWatch.
For many, one of the shining moments in the COVID-19 pandemic was learning that the mRNA vaccines developed by Moderna MRNA and BioNTech BNTX/Pfizer PFE worked.
Then came the first wave of breakthrough infections in mid-2021 and the gradual understanding, both in scientific circles and among the general public, that the vaccines are far less powerful protectors against infection than we initially thought even though they still do a pretty great job preventing severe disease.
In the U.S., there are no authorized or approved intranasal vaccines, though there are several in development, including Blue Lake Biotechnology Inc.’s experimental vaccine, which produced promising data from a Phase 1 clinical trial, and Codegenix Inc.’s candidate, which is in Phase 3 clinical trials. Both companies are privately held.
MarketWatch: So what we’re actually talking about are the endpoints for the clinical trials and the benchmarks for authorization, approval, or licensing. Hombach: I cannot really speak for the regulators, but my understanding is that’s not the case. We will be going with the criteria that we have, but the value add needs to be studied subsequently in some type of effectiveness studies. We’d like to have this for any vaccine. But we would also like to have it for nasal vaccines. And the data for licensure will not provide this information.
MarketWatch: What do you think people still need to understand about the vaccines that hasn’t resonated yet? Are there still challenging messages to get across?
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Silicon Valley Bank collapse could be a big win for Big TechHere are 3 reasons to be deeply concerned about the Silicon Valley Bank collapse. (via The ReidOut Blog)
Read more »
Alabama Marks Three Years Since First COVID Case - Alabama NewsIt was Friday the 13th of March, 2020, that state health officials announced Alabama's first COVID case, which was in Montgomery County. alnews covid wakanews
Read more »
COVID three years later, ADPH shares where the state is nowMonday, March 13th 2023 marks exactly three years since Alabama confirmed its first case of COVID.
Read more »
Powerful AI models, and more — this week’s best science graphicsThree charts from the world of research, selected by Nature editors.
Read more »
Three years after COVID-19: Lasting effects of disruptions for childrenThree years since the Trump administration first declared the COVID-19 pandemic a national emergency, children and teenagers are still experiencing the lasting effects of pandemic-era lockdowns and disruptions to daily life, from exacerbated mental health problems to increased vulnerabilities to…
Read more »